The appointment of the Qualified Person is one of the key steps in the process toward GMP authorization. This is the figure responsible for certifying and releasing every single batch of medicinal product: a legal and personal responsibility that cannot be delegated.
The requirements are defined in Article 52 of Italian Legislative Decree 219/2006: a university degree in a scientific discipline, registration with the professional association, and at least two years of documented practical experience in an authorized manufacturing facility.
In the case of ATMPs (advanced therapy medicinal products), those two years of experience are not generic: they must have been gained in the same type of production for which the QP will perform their duties. This is a substantive, not merely bureaucratic, requirement that reflects the technical and regulatory complexity of these products.
The appointment is reported to AIFA (the Italian Medicines Agency) and is formally linked to the manufacturing authorization. Without a designated QP, no batch can be released.
As part of our journey toward GMP authorization, we have identified within our team the professional who will take on this role: Marta Tapparo, a biologist and senior researcher with 15 years of experience in both academia and industry. Throughout her career, she has developed expertise in research, quality and GMP contexts, standing out for her precision, analytical approach, and problem-solving skills.
Every step toward GMP authorization means investing in expertise, accountability and quality.